Filing Details
- Accession Number:
- 0001209191-21-058517
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-01 17:11:43
- Reporting Period:
- 2021-09-01
- Accepted Time:
- 2021-10-01 17:11:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1075050 | J A Kazimi | 2525 West End Ave. Suite 950 Nashville TN 37203 | Chairman And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-09-01 | 15 | $2.88 | 5,766,159 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-02 | 15 | $2.88 | 5,769,174 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-03 | 15 | $2.85 | 5,769,189 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-07 | 15 | $2.79 | 5,769,204 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-08 | 15 | $2.89 | 5,769,219 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-09 | 15 | $2.77 | 5,769,234 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-10 | 15 | $2.78 | 5,769,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-13 | 15 | $2.96 | 5,769,264 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-14 | 15 | $3.02 | 5,769,279 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-15 | 15 | $2.86 | 5,769,294 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-16 | 15 | $2.91 | 5,769,309 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-17 | 15 | $2.85 | 5,769,324 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-20 | 15 | $2.82 | 5,769,339 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-21 | 15 | $2.81 | 5,769,354 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-22 | 15 | $2.76 | 5,769,369 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-23 | 15 | $2.75 | 5,769,384 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-24 | 15 | $2.74 | 5,769,399 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-27 | 15 | $2.79 | 5,769,414 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-28 | 15 | $2.76 | 5,769,429 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-29 | 15 | $2.82 | 5,769,444 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-30 | 15 | $2.72 | 5,769,459 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
Billionaire Hedge Funds
